GK (glucokinase) is an enzyme central to glucose metabolism that displays positive co-operativity to substrate glucose. Small-molecule GKAs (GK activators) modulate GK catalytic activity and glucose affinity and are currently being pursued as a treatment for Type 2 diabetes. GK progress curves monitoring product formation are linear up to 1 mM glucose, but biphasic at 5 mM, with the transition from the lower initial velocity to the higher steady-state velocity being described by the rate constant kact. In the presence of a liver-specific GKA (compound A), progress curves at 1 mM glucose are similar to those at 5 mM, reflecting activation of GK by compound A. We show that GKRP (GK regulatory protein) is a slow tight-binding inhibitor of GK. Analysis of progress curves indicate that this inhibition is time dependent, with apparent initial and final Ki values being 113 and 12.8 nM respectively. When GK is pre-incubated with glucose and compound A, the inhibition observed by GKRP is time dependent, but independent of GKRP concentration, reflecting the GKA-controlled transition between closed and open GK conformations. These data are supported by cell-based imaging data from primary rat hepatocytes. This work characterizes the modulation of GK by a novel GKA that may enable the design of new and improved GKAs.
Skip Nav Destination
Article navigation
February 2012
-
Cover Image
Cover Image
- PDF Icon PDF LinkFront Matter
- PDF Icon PDF LinkTable of Contents
- PDF Icon PDF LinkEditorial Board
Research Article|
January 16 2012
Modulation of glucokinase by glucose, small-molecule activator and glucokinase regulatory protein: steady-state kinetic and cell-based analysis
Francis J. Bourbonais;
Francis J. Bourbonais
1Pfizer Global Research and Development, Eastern Point Road, Groton, CT 06340, U.S.A.
Search for other works by this author on:
Jing Chen;
Jing Chen
1Pfizer Global Research and Development, Eastern Point Road, Groton, CT 06340, U.S.A.
Search for other works by this author on:
Cong Huang;
Cong Huang
1Pfizer Global Research and Development, Eastern Point Road, Groton, CT 06340, U.S.A.
Search for other works by this author on:
Yanwei Zhang;
Yanwei Zhang
1Pfizer Global Research and Development, Eastern Point Road, Groton, CT 06340, U.S.A.
Search for other works by this author on:
Jeffrey A. Pfefferkorn;
Jeffrey A. Pfefferkorn
1Pfizer Global Research and Development, Eastern Point Road, Groton, CT 06340, U.S.A.
Search for other works by this author on:
James A. Landro
James A. Landro
1
1Pfizer Global Research and Development, Eastern Point Road, Groton, CT 06340, U.S.A.
1To whom correspondence should be addressed (email James.Landro@pfizer.com).
Search for other works by this author on:
Publisher: Portland Press Ltd
Received:
April 21 2011
Revision Received:
October 20 2011
Accepted:
November 01 2011
Accepted Manuscript online:
November 01 2011
Online ISSN: 1470-8728
Print ISSN: 0264-6021
© The Authors Journal compilation © 2012 Biochemical Society
2012
Biochem J (2012) 441 (3): 881–887.
Article history
Received:
April 21 2011
Revision Received:
October 20 2011
Accepted:
November 01 2011
Accepted Manuscript online:
November 01 2011
Citation
Francis J. Bourbonais, Jing Chen, Cong Huang, Yanwei Zhang, Jeffrey A. Pfefferkorn, James A. Landro; Modulation of glucokinase by glucose, small-molecule activator and glucokinase regulatory protein: steady-state kinetic and cell-based analysis. Biochem J 1 February 2012; 441 (3): 881–887. doi: https://doi.org/10.1042/BJ20110721
Download citation file:
Sign in
Don't already have an account? Register
Sign in to your personal account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.